Show simple item record

dc.creatorRijo, Patricia
dc.creatorAthanassopoulos, Constantinos M.
dc.creatorCarpinella, María Cecilia
dc.date2022-12-07
dc.date.accessioned2023-04-10T17:50:26Z
dc.date.available2023-04-10T17:50:26Z
dc.identifierhttp://pa.bibdigital.ucc.edu.ar/3650/1/A_Rijo_Athanassopoulos_Carpinella.pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12032/86102
dc.descriptionDespite the great benefits of chemotherapy, the ability of tumor cells to acquire crossresistance to multiple antineoplastic drugs (MDR) results in a drastic reduction in the efficacy of these agents. Of greatest concern is the consequent failure in clinical practice, which remains one of the major barriers to successful cancer treatment. To improve patient outcome, novel efficacious anti-cancer agents or approaches to reverse MDR are necessary. Plants have been an endless and vital source of pharmacologically active compounds, many of which are widely used in cancer therapies, not only to control tumor cells, but also to increase their sensitivity to chemotherapeutic agents. The structural diversity and array of biological properties of plant-derived metabolites, in particular against tumors, make these strong candidates to combat MDR cells or establish their scaffolds as a valuable base for the synthesis of derivatives. This enormous potential of plants to tackle MDR tumors encouraged us to publish this Research Topic to display and discuss the cutting-edge research in the field. As editors, it was a pleasure to review a wide range of fascinating articles with different perspectives, and we summarize here the main findings of accepted articles.
dc.descriptionFil: Rijo, Patricia. Universidade Lusófona Research Center for Biosciences & Health Technologies; Portugal
dc.descriptionFil: Athanassopoulos, Constantinos M. University of Patras; Grecia
dc.descriptionFil: Carpinella, María Cecilia. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina
dc.formatapplication/pdf
dc.languagespa
dc.relationhttp://pa.bibdigital.ucc.edu.ar/3650/
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.3389/fphar.2022.1108252
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.sourceRijo, Patricia, Athanassopoulos, Constantinos M. ORCID: https://orcid.org/0000-0002-7549-1911 <https://orcid.org/0000-0002-7549-1911> and Carpinella, María Cecilia ORCID: https://orcid.org/0000-0001-5553-1851 <https://orcid.org/0000-0001-5553-1851> (2022) Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors. Frontiers in pharmacology. 01-02. ISSN 1663-9812
dc.subjectQD Química
dc.titleEditorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/acceptedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record


© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP